首页|类器官培养技术及其在神经母细胞瘤研究中的应用

类器官培养技术及其在神经母细胞瘤研究中的应用

扫码查看
类器官(Organoids)是一种体外培养的由干细胞分化而来的自组装三维细胞团,具有干细胞对应组织器官的细胞类型和复杂空间形态,能够模拟组织器官的部分功能和生理反应,与来源组织具有极高的相似性,尤其是患者来源的组织类器官,更能够反应患者的基因异质性、组织结构、分子特征。近年来类器官培养技术发展迅速,为医学研究提供了可靠的临床前疾病模型和药物筛选途径,在多种疾病研究中展现了巨大潜能和技术优势。本文介绍了类器官培养技术起源及其进展,从类器官培养技术的建立、类器官培养的细胞来源、类器官培养中小分子添加剂的功能以及各种类器官培养方式的应用场景等作了详细介绍,并综述了类器官培养技术在神经母细胞瘤研究中的发展与应用。
Organoid culture technologies and their applications in neuroblastoma
Organoids are a self-assembled,three-dimensional cellular aggregate that is cultivated from stem cells in vitro.These structures possess cellular diversity and intricate spatial morphology that closely resemble the stem cells found in various tissues and organs.Furthermore,they are capable of emulating certain functions and physiologi-cal responses of tissues and organs.Notably,organoids derived from patients exhibit a remarkable resemblance to the source tissues,thereby enabling the representation of patients'genetic heterogeneity,tissue structure,and molecular attributes.In recent years,there has been significant advancement in the field of organoid culture technology,which has emerged as a dependable preclinical disease model and drug screening platform for medical research.This technol-ogy has demonstrated immense potential and technical advantages in diverse areas of disease research.This paper pro-vides a comprehensive overview of the origins and advancements in organoid culture technology,encompassing the es-tablishment of this technology,the cellular sources utilized in organoid culture,the role of small molecular additives in facilitating organoid culture,and the diverse application scenarios of various organoid culture methods.In addition,the application of organoid culture technology in neuroblastoma research is reviewed.The organoid disease model will bring new hope for the basic and clinical research of neuroblastoma.

Organoids3D cell culturePluripotent stem cellsNeuroblastomaPersonalized therapy

李俏、杨燕

展开 >

华中科技大学同济医学院附属同济医院实验医学研究中心,武汉 430030

类器官 3D细胞培养 多能干细胞 神经母细胞瘤 个体化治疗

湖北省自然基金项目

2019CFB440

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(7)
  • 64